Stay updated on AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Sign up to get notified when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.

Latest updates to the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page
- Check4 days agoChange DetectedVersion revision on the page was updated from v3.6.2 to v3.6.3, representing a minor update to the site's page template or backend. No study content or data changes are implied by this update.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision: v3.6.2 appears on the page, replacing the previous v3.6.0. This indicates a minor platform update rather than changes to the study data.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded posted results for the AFPc332T study (NCT03132792), including safety endpoints (DLTs, TEAEs, SAEs), efficacy endpoints (ORR, DoR, PFS, OS), and enrollment details (39 participants). Also added access to official documents (Study Protocol and SAP) and updated results timing information (results posted/submitted dates).SummaryDifference3%

- Check26 days agoChange DetectedDifference0.4%

- Check33 days agoChange DetectedThe page's revision label has been updated from v3.5.4 to v3.5.5, signaling a minor update to the page's underlying version tracking.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This indicates a small site update without changes to study information.SummaryDifference0.0%

Stay in the know with updates to AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.